Hepion Pharmaceuticals SG&A Expense (TTM) Analysis

Hepion Pharmaceuticals Inc (HEPA)

0.68 -0.01 (-1.45%) USD | NASDAQ | Sep 27, 16:00

0.661 -0.02 (-2.79%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
June 30, 2024	7.932M
March 31, 2024	8.850M
December 31, 2023	9.618M
September 30, 2023	10.10M
June 30, 2023	10.68M
March 31, 2023	10.82M
December 31, 2022	10.35M
September 30, 2022	10.18M
June 30, 2022	10.17M
March 31, 2022	10.42M
December 31, 2021	10.01M
September 30, 2021	10.24M
June 30, 2021	9.976M
March 31, 2021	9.132M
December 31, 2020	8.149M
September 30, 2020	7.002M
June 30, 2020	5.617M
March 31, 2020	4.732M
December 31, 2019	4.586M
September 30, 2019	5.361M

Date	Value
June 30, 2019	5.982M
March 31, 2019	6.803M
December 31, 2018	7.000M
September 30, 2018	6.922M
June 30, 2018	7.194M
March 31, 2018	7.396M
September 30, 2017	7.499M
June 30, 2017	7.372M
March 31, 2017	7.185M
December 31, 2016	6.688M
September 30, 2016	6.455M
June 30, 2016	5.786M
March 31, 2016	5.802M
December 31, 2015	6.128M
September 30, 2015	5.937M
June 30, 2015	5.556M
March 31, 2015	4.422M
December 31, 2014	3.016M
September 30, 2014	1.890M
June 30, 2014	1.358M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

4.586M

Minimum

Dec 2019

10.82M

Maximum

Mar 2023

8.696M

Average

9.797M

Median

SG&A Expense (TTM) Benchmarks